Article

Lactobacillus rhamnosus GG의 건강 증진 효과

임광세*, 김주용, 예현수, 김창민
Kwang-Sei Lim*, Ju-Yong Kim, Hyun-Soo Yea, Chang-Min Kim
Author Information & Copyright
매일유업㈜ 중앙연구소
R & D Center, Maeil Dairies Co., Ltd., Pyeongtaek 451-861, Korea
*Corresponding author: Kwang-Sei Lim, R&D Center, Maeil Dairies Co., Ltd., Pyeongtaek 451-861, Korea. Tel: 82-31-612-3900, E-mail: kwangslim@maeil.com

Copyright © Korean Society for Lactic Acid Bacteria. All rights reserved. This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Published Online: Jun 30, 2019

Abstract

Lactobacillus rhamnosus GG (ATCC 53103, LGG) is one of the most researched probiotic strains in the world. It has been studied extensively in humans and experimental animals for a wide variety of uses. L. rhamnosus GG was isolated from an adult human in 1983, and it has a safe history of use in food products since 1990. The strain has most of the characteristics generally proposed for a good probiotic strain, including excellent survival in and transient colonization of the gastrointestinal tract, which is based on its adhesion capacity to intestinal mucus and epithelial cells. Successful recovery of the strain in stool samples has made dose-response studies possible and enabled the evaluation of effective dosing using food products. L. rhamnosus GG has also been found to have many beneficial health effects on gastrointestinal infection, antibiotic associated diarrhea, respiratory infection, viral infection and allergy.

Keywords: Lactobacillus rhamnosus GG; immunity; gastrointestinal infection; respiratory infection; allergy; irritable bowel disease